A Study of the Effect of Different Doses of Difluprednate Eye Drops on the Intraocular Pressure After Phacoemulsification

Launched by KAFRELSHEIKH UNIVERSITY · Dec 12, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how different doses of difluprednate eye drops can help reduce inflammation in the eye after cataract surgery, specifically phacoemulsification, while also keeping eye pressure at a safe level. Researchers want to find out the smallest effective dose that can be safely used within the first 24 hours after surgery. The goal is to improve recovery without causing any unwanted side effects.

To participate in this study, you should be between 40 and 80 years old and have a specific type of cataract. It’s important that you haven’t had any previous eye conditions like uveitis or complications during your surgery. If you join the trial, you'll receive eye drops and be monitored to see how well they work for you. This study is currently looking for participants, and it aims to help improve care for patients undergoing cataract surgery in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 40-80
• • Grade 1 to 4 nuclear cataract LOCS II
• • Cumulative dissipated energy CDE 1 to 10
• • Done by a single surgeon using the chopping technique
• Exclusion Criteria:
• • History of uveitis
• • the use of topical or systemic steroids on the last post-operative day
• • Intraoperative or postoperative complications
• • Intraoperative iris manipulations or phaco traume

Trial Officials